Serum neuroendocrine (NE) markers and clinical characteristics of treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) in men with metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Aggarwal, RR; Zhang, L; Beer, TM; Youngren, J; Stromlund, A; Bell, A; Foye, A; Playdle, D; Alumkal, JJ; Reiter, RE; Gleave, M; Evans, CP; Thomas, GV; Huang, J; True, LD; Rettig, M; Lara, P; Chi, KN; Small, EJ

Published Date

  • February 20, 2018

Published In

Volume / Issue

  • 36 / 6_suppl

Start / End Page

  • 278 - 278

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.6_suppl.278